Tenaya Therapeutics (TNYA) Change in Account Payables (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Change in Account Payables of -$1.5 million for Q1 2026, down 285.22% year-over-year from $788233.6 in Q1 2025, and down 374.95% quarter-over-quarter from $531000.0 in Q4 2025.
Tenaya Therapeutics (TNYA) Change in Account Payables (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 285.22% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$2.5 million (down 12.5% YoY), while the FY2025 annual figure was -$1.4 million, down 146.13% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$1.5 million, down from $531000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $3.5 million in Q4 2022, with the low at -$2.8 million in Q3 2023.
- The 5-year median for Change in Account Payables is -$379000.0 (2025), against an average of -$299588.2.
- Peak annual rise in Change in Account Payables reached 422.87% in 2023, while the deepest fall reached 968.77% in 2023.
- Tenaya Therapeutics' Change in Account Payables stood at $3.5 million in 2022, then sank by 108.81% to -$305000.0 in 2023, then sank by 129.84% to -$701000.0 in 2024, then soared by 175.75% to $531000.0 in 2025, then tumbled by 374.95% to -$1.5 million in 2026.
- Business Quant data shows TNYA's Change in Account Payables at -$1.5 million in Q1 2026, $531000.0 in Q4 2025, and -$447000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - | 988,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 988,000.00 |
| Jun 30, 2026 | 988,000.00 |
| Mar 31, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.46 Mn |
| Dec 31, 2025 | 531,000.00 |
| Dec 31, 2025 | 531,000.00 |
| Sep 30, 2025 | -447,000.00 |
| Sep 30, 2025 | -447,000.00 |
| Jun 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -379,000.00 |
| Mar 31, 2025 | -379,000.00 |
| Dec 31, 2024 | -701,000.00 |
| Dec 31, 2024 | -701,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.27 Mn |